IDT Biologika

IDT Biologika is a global contract development and manufacturing organization (CDMO) and part of SK bioscience, serving pharmaceutical and biotechnology companies as well as governments. Founded in 1921, the company brings more than a century of experience in vaccine development and production, supported by approximately 1,600 employees and facilities including two BSL-2 sites. It provides end-to-end services for vaccines, cell and gene therapies, immune therapeutics, biosimilars, and sterile injectable medicines.

IDT Biologika supports products throughout their lifecycle, from cell-line selection, process and analytical development, and technology transfer to clinical and commercial manufacturing. Its biomanufacturing capabilities include drug-substance production using cell-culture and microbial processes, as well as viral-vector manufacturing. For drug products, the company offers aseptic liquid filling and lyophilization in vials and pre-filled syringes, alongside secondary packaging, cold-chain storage, quality control, analytics, and regulatory support. With experience in live viral products, proprietary technologies, and regulatory approvals including EMA and FDA, IDT Biologika helps customers develop, scale, and manufacture biopharmaceutical products.